J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700102-JLR200 on July 3, 2007

Papers In Press, published online ahead of print October 1, 2007
J. Lipid Res., doi:10.1194/jlr.M700102-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700102-JLR200v1
48/10/2193    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atshaves, B. P.
Right arrow Articles by Schroeder, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atshaves, B. P.
Right arrow Articles by Schroeder, F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 2193-2211, October 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytesboxs

Barbara P. Atshaves*, Avery L. McIntosh*, H. Ross Payne{dagger}, Adalberto M. Gallegos{dagger}, Kerstin Landrock*, Nobuyo Maeda§, Ann B. Kier{dagger} and Friedhelm Schroeder1,*

* Department of Physiology and Pharmacology, Texas A&M University, Texas Veterinary Medical Center, College Station, TX 77843-4466
{dagger} Department of Pathobiology, Texas A&M University, TVMC, College Station, TX 77843-4467
§ Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7525

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of one figure and five tables.

Published, JLR Papers in Press, July 3, 2007.

1 To whom correspondence should be addressed. e-mail: fschroeder{at}cvm.tamu.edu

Although reverse cholesterol transport from peripheral cell types is mediated through plasma membrane microdomains termed lipid rafts, almost nothing is known regarding the existence, protein/lipid composition, or structure of these putative domains in liver hepatocytes, cells responsible for the net removal of cholesterol from the body. Lipid rafts purified from hepatocyte plasma membranes by a nondetergent affinity chromatography method were: i) present at 33 ± 3% of total plasma membrane protein; ii) enriched in key proteins of the reverse cholesterol pathway [scavenger receptor class B type I (SR-B1), ABCA1, P-glycoprotein (P-gp), sterol carrier protein-2 (SCP-2)]; iii) devoid of caveolin-1; iv) enriched in cholesterol, sphingomyelin, GM1, and phospholipids low in polyunsaturated fatty acid and double bond index; and v) exhibited an intermediate liquid-ordered lipid phase with significant transbilayer fluidity gradient. Ablation of the gene encoding SCP-2 significantly altered lipid rafts to: i) increase the proportion of lipid rafts present, thereby increasing raft total content of ABCA1, P-gp, and SR-B1; ii) increase total phospholipids while decreasing GM1 in lipid rafts; iii) decrease the fluidity of lipid rafts, consistent with the increased intermediate liquid-ordered phase; and iv) abolish the lipid raft transbilayer fluidity gradient. Thus, despite the absence of caveolin-1 in liver hepatocytes, lipid rafts represented nearly one-third of the mouse hepatocyte plasma membrane proteins and displayed unique protein, lipid, and biophysical properties that were differentially regulated by SCP-2 expression.

Supplementary key words sterol carrier protein • SR-B1 • reverse cholesterol transport • ABCA1

Abbreviations: apoA-I, apolipoprotein A-I; cis-parinaric acid, 9Z,11E,13E,15Z-octatetradecanoic acid; ConA, concanavalin A; DBI, double bond index; DHE, dehydroergosterol; DPH, 1,6-diphenyl-1,3,5-hexatriene; DPH-Pro, 3(1,6-diphenyl-1,3,5-hexatrienyl)-propionic acid; DPH-TMA, 1,6-diphyenyl-1,3,5-hexatrienyl-trimethylammonium; eNOS, endothelial nitic oxide synthase; L-FABP, liver fatty acid binding protein; NBD-stearic acid, 12-(N-methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-octadecanoic acid; PA, phosphatidic acid; PC, choline glycerophospholipid; PE, ethanolamine glycerophospholipid; P-gp, P-glycoprotein; PI, phosphatidylinositol; PS, phosphatidylserine; RCT, reverse cholesterol transport; SCP-2, sterol carrier protein-2; SM, sphingomyelin; SR-B1, scavenger receptor class B type I


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.